Deerfield Private Design Fund III, L.P.
CIK 0001603333
Director10% Owner
Filings
6
Latest Mar 2, 2026
Issuers covered
3
Showing
6 of 6
Page 1
Track record
20 of 20 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 20 | 55% | +2.8% | +7.2% | +29.8% | -34.7% |
| 90 days | 20 | 65% | +7.7% | +26.9% | +47.6% | -41.9% |
| 180 days | 16 | 81% | +9.1% | +20.0% | +36.9% | -40.8% |
| 365 days | 11 | 73% | +14.6% | +46.1% | +49.9% | -74.3% |
Issuers
Companies where Deerfield Private Design Fund III, L.P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| LRMR | Larimar Therapeutics, Inc. | 3 | Mar 2, 2026 |
| SPRY | Ars Pharmaceuticals, Inc. | 2 | Jul 1, 2025 |
| GUTS | Fractyl Health, Inc. | 1 | Feb 8, 2024 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|